Healthcare provider profile · identity verified

Marsha A Taylor, MD

Family Practice · OZARK, MO · NPI 1780686196

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	290	81
Atorvastatin Calcium	Atorvastatin Calcium	260	77
Gabapentin	Gabapentin	239	74
Metoprolol Succinate	Metoprolol Succinate	237	82
Omeprazole	Omeprazole	232	87
Levothyroxine Sodium	Levothyroxine Sodium	231	71
Tramadol Hcl	Tramadol Hcl	203	43
Amlodipine Besylate	Amlodipine Besylate	196	62
Rosuvastatin Calcium	Rosuvastatin Calcium	185	69
Lisinopril	Lisinopril	175	50
Montelukast Sodium	Montelukast Sodium	156	59
Metformin Hcl	Metformin Hcl	137	43
Trazodone Hcl	Trazodone Hcl	132	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	32
Simvastatin	Simvastatin	118	33
Tizanidine Hcl	Tizanidine Hcl	113	38
Alendronate Sodium	Alendronate Sodium	111	39
Albuterol Sulfate Hfa	Albuterol Sulfate	99	49
Spironolactone	Spironolactone	99	30
Fluticasone Propionate	Fluticasone Propionate	98	39
Eliquis	Apixaban	91	22
Meloxicam	Meloxicam	89	34
Metoprolol Tartrate	Metoprolol Tartrate	89	24
Duloxetine Hcl	Duloxetine Hcl	84	21
Pregabalin	Pregabalin	82	23
Hydrochlorothiazide	Hydrochlorothiazide	81	29
Alprazolam	Alprazolam	80	21
Ozempic	Semaglutide	77	20
Ondansetron Hcl	Ondansetron Hcl	76	26
Tamsulosin Hcl	Tamsulosin Hcl	74	26
Pantoprazole Sodium	Pantoprazole Sodium	67	18
Warfarin Sodium	Warfarin Sodium	66	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	62	20
Bupropion Xl	Bupropion Hcl	60	18
Memantine Hcl	Memantine Hcl	60	11
Donepezil Hcl	Donepezil Hcl	59	14
Potassium Chloride	Potassium Chloride	54	19
Farxiga	Dapagliflozin Propanediol	52	13
Trulicity	Dulaglutide	50	14
Arexvy	Rsvpref3 Antigen/As01e/Pf	48	48
Furosemide	Furosemide	45	15
Metformin Hcl Er	Metformin Hcl	45	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Lovastatin	Lovastatin	44	14
Carvedilol	Carvedilol	43	16
Allopurinol	Allopurinol	42	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	13
Eszopiclone	Eszopiclone	40	suppressed
Mounjaro	Tirzepatide	40	suppressed
Valacyclovir	Valacyclovir Hcl	40	13
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Sertraline Hcl	Sertraline Hcl	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	32
Citalopram Hbr	Citalopram Hydrobromide	36	13
Propranolol Hcl Er	Propranolol Hcl	36	suppressed
Famotidine	Famotidine	34	16
Bumetanide	Bumetanide	32	14
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Clonazepam	Clonazepam	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	11
Mupirocin	Mupirocin	27	21
Oxybutynin Chloride	Oxybutynin Chloride	27	12
Prednisone	Prednisone	27	suppressed
Topiramate	Topiramate	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Levofloxacin	Levofloxacin	25	23
Lorazepam	Lorazepam	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Valsartan	Valsartan	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Xarelto	Rivaroxaban	18	suppressed
Baclofen	Baclofen	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	12
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Aripiprazole	Aripiprazole	16	suppressed
Estradiol	Estradiol	16	11
Lansoprazole	Lansoprazole	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Celecoxib	Celecoxib	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	12
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Temazepam	Temazepam	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Glipizide	Glipizide	13	suppressed
Atenolol	Atenolol	12	suppressed
Azithromycin	Azithromycin	12	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Finasteride	Finasteride	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Glipizide Er	Glipizide	11	suppressed
Nystatin	Nystatin	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Ubrelvy	Ubrogepant	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error